Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - STOCK-BASED COMPENSATION
Stock-based Compensation AKBA - Akebia Therapeutics, Inc.
9.32 M
LAST VALUE
-35.98%
2 YEAR CAGR
-13.32%
5 YEAR CAGR
19.54%
10 YEAR CAGR